Cytovac Ab Is A Danish Biotechnology Company That Specializes In Immunotherapy For Cancer Treatmentfounded In 2008It Operates Under The Parent Entity Cytovac A S And Is Based In Ha Rsholmdenmarkthe Company Utilizes Its Proprietary Alecsat Technology Platform To Activate The Bodyae S Immune Systemtargeting Cancer Cells While Minimizing Side Effects Through Patient Specific Therapies Cytovac Offers Alecsat Therapya Cell Based Immunotherapy That Uses Activated Immune Cells Derived From Patients To Treat Various Cancersincluding Brainprostateand Pancreatic Cancersthe Company Also Provides Gmp Manufacturing For Cell Therapiesclinical Trial Supportand Engages In R&D Partnerships With Other Biotech Firmswith A Focus On Immune System Modulation And Transcription Factor Engineeringcytovac Holds Five Patentsincluding One For An Anti Tumor Vaccine Targeting Cancer Specific Markersits Team Consists Of Experts In Immunologyoncologyand Cell Biologycollaborating With Scandinavian Hospitals And Contract Research Organizations
